BridgeMD
New treatment option for Hip Arthroplasty
Official title DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
ClinicalTrials.gov ID: NCT07452120
What this study is testing
- What it's testing
- This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged ≥18 years
- ASA physical status I-III
- Scheduled for elective primary total hip arthroplasty under spinal anesthesia
- Ability to understand the study procedures and provide informed consent
You likely can't join if
- Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
- Infection at the block application site
- Hemodynamic instability
- Known allergy to local anesthetics
- Pre-existing significant neurological or motor deficits in the lower extremities
- Cognitive impairment preventing pain assessment
See the full eligibility criteria
- Patients aged ≥18 years
- ASA physical status I-III
- Scheduled for elective primary total hip arthroplasty under spinal anesthesia
- Ability to understand the study procedures and provide informed consent
- Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
- Infection at the block application site
- Hemodynamic instability
- Known allergy to local anesthetics
- Pre-existing significant neurological or motor deficits in the lower extremities
- Cognitive impairment preventing pain assessment
- Refusal to participate or inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Sivas, Sivas, Turkey (Türkiye)
- Sivas, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sivas, Sivas, Turkey (Türkiye); Sivas, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.